New Single-Dose Malaria Treatment Shows Promise Amidst Drug Resistance
A new drug called GanLum shows promise as an effective alternative to artemisinin-based treatments for malaria, especially in areas facing resistance issues, potentially extending the lifespan of current therapies and saving lives.